SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Lel H who wrote (716)6/15/1999 9:52:00 PM
From: Edscharp  Read Replies (1) | Respond to of 1139
 
Just thought I'd pop in for a moment and confirm that ICOS is still on my watch list.



To: Lel H who wrote (716)6/15/1999 11:41:00 PM
From: DJ  Read Replies (2) | Respond to of 1139
 
Definitely a setback, but what a time to pick up this stock at a bargain price. Leukarrest wasn't Icos's prime pipeline drug, and plenty of stuff is still in the works. Rathmann has built a terrific team of managers backing him up, and adds top-level scientists all the time. This stock is gonna pay my grandkids' tuition bills at Stanford.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News